Sikander Ailawadhi, M.D.

  • Multiple myeloma
  • Waldenstrom's macroglobulinemia
  • Chronic leukemias (chronic lymphocytic leukemi; CLL, chronic myeloid leukemia; CML)
  • Clinical drug development in multiple myeloma and Waldenstrom's macroglobulinemia
  • Healthcare disparities and outcomes
  • Cancer disparities among ethnic minorities
  • Biological variability in plasma cell dyscrasia

Jacksonville, Florida

  1. 2008
    Fellow - Medical OncologyRoswell Park Cancer Institute, State University of New York at Buffalo
  2. 2006
    Resident - Internal MedicineState University of New York at Buffalo
  3. 2003
    Resident - Medical MicrobiologyUniversity College of Medical Sciences, University of Delhi
  4. 2000
    MBBSUniversity College of Medical Sciences and Guru Teg Bahadur Hospital, University of Delhi


  1. Internal MedicineAmerican Board of Internal Medicine
  2. Medical OncologyAmerican Board of Internal Medicine

Professional Highlights

  1. National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2013
  2. Top Doctor Award, Pasadena Magazine 2012, 2013
  3. Member, Peer Review Committee (Chronic Lymphocytic Leukemia), American Society of Hematology (ASH), 2009, 2011
  4. Member, Educational Committee, American Society of CLinical Oncology (ASCO), 2010
  5. South West Oncology Group (SWOG) Young Investigator Award, 2010
  6. Fellow, ASCO/AACR Methods in Clinical Cancer Research, 2008
  7. Best Clinical Science Research, Roswell Park Cancer Institute, Buffalo NY, 2008
  8. J. Frederick Painton, M.D. Memorial Award for Outstanding Resident and Excellence in Teaching, State University of New York at Buffalo NY, 2006
  9. Lawrence H. Golden, M.D. Award for Humanistic and Scientific Excellence in Patient Care, State University of New York at Buffalo NY, 2004